Beta-thalassemia
Open accessThe DOI matches its Crossref record; 4 of the 89 references it cites were found in a registry or an index, and 85 are not checked yet.
Abstract
Beta-thalassemia is caused by the reduced (beta) or absent (beta) synthesis of the beta globin chains of the hemoglobin tetramer. Three clinical and hematological conditions of increasing severity are recognized, i.e., the beta-thalassemia carrier state, thalassemia intermedia, and thalassemia major. The beta-thalassemia carrier state, which results from heterozygosity for beta-thalassemia, is clinically asymptomatic and is defined by specific hematological features. Thalassemia major is a severe transfusion-dependent anemia. Thalassemia intermedia comprehend a clinically and genotypically very heterogeneous group of thalassemia-like disorders, ranging in severity from the asymptomatic carrier state to the severe transfusion-dependent type. The clinical severity of beta-thalassemia is related to the extent of imbalance between the alpha and nonalpha globin chains. The beta globin (HBB) gene maps in the short arm of chromosome 11, in a region containing also the delta globin gene, the embryonic epsilon gene, the fetal A-gamma and G-gamma genes, and a pseudogene (psiB1). Beta-thalassemias are heterogeneous at the molecular level. More than 200 disease-causing mutations have been so far identified. The majority of mutations are single nucleotide substitutions, deletions, or insertions of oligonucleotides leading to frameshift. Rarely, beta-thalassemia results from gross gene deletion. In addition to the variation of the phenotype resulting from allelic heterogeneity at the beta globin locus, the phenotype of beta-thalassemia could also be modified by the action of genetic factors mapping outside the globin gene cluster and not influencing the fetal hemoglobin. Among these factors, the ones best delineated so far are those affecting bilirubin, iron, and bone metabolisms. Because of the high carrier rate for HBB mutations in certain populations and the availability of genetic counseling and prenatal diagnosis, population screening is ongoing in several at-risk populations in the Mediterranean. Population screening associated with genetic counseling was extremely useful by allowing couples at risk to make informed decision on their reproductive choices. Clinical management of thalassemia major consists in regular long-life red blood cell transfusions and iron chelation therapy to remove iron introduced in excess with transfusions. At present, the only definitive cure is bone marrow transplantation. Therapies under investigation are the induction of fetal hemoglobin with pharmacologic compounds and stem cell gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload
Anderson, L. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2822 · Cited by 1,682
Common West African HLA antigens are associated with protection from severe malaria
Hill, A. V. S., Allsopp, C. E. M., Kwiatkowski, D., Anstey, N. M., Twumasi, P., Rowe, P. A., Bennett, S., Brewster, D., McMichael, A. J., & Greenwood, B. M. (1991) · Nature · doi:10.1038/352595a0 · Cited by 1,552
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
Ganz, T. (2003) · Blood · doi:10.1182/blood-2003-03-0672 · Cited by 1,544
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin
Hanna, J., Wernig, M., Markoulaki, S., Sun, C.-W., Meissner, A., Cassady, J. P., Beard, C., Brambrink, T., Wu, L.-C., Townes, T. M., et al. (2007) · Science · doi:10.1126/science.1152092 · Cited by 1,202
Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria
McGuire, W., Hill, A. V. S., Allsopp, C. E. M., Greenwood, B. M., & Kwiatkowski, D. (1994) · Nature · doi:10.1038/371508a0 · Cited by 1,169
Rund, D., & Rachmilewitz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050436 · Cited by 939
Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H. (2008) · Science · doi:10.1126/science.1165409 · Cited by 919
Research works printed but not linked: 5
- Wheatherall DJ, Clegg JB. The thalassemia syndromes. 4th ed. Oxford, England: Blackwell Science Ltd, 2001.
- Weatherall DJ, Clegg JB, Higgs DR, Wood WG. The hemoglobinopathies. In: Scriver CR, Beaudet Al, Sly WS, Valle D, Vogelstein B, editors. The metabolic and molecular bases of inherited disease (OMMBID). Chapter 101. New York, NY: McGraw-Hill, 2002. Available at: www.ommbid.com. Accessed December 31, 2007.
- Rees, 1998, Genetic influenes on bone disease in thalassemia, Blood, 92, S532a
- Dresner Pollak, 2000, Bone mineral metabolism in adults with beta thalassemia major and intermedia, Br J Haematol, 111, 902
- Galanello, 1990, Deletion delta-thalassemia: the 7.2 kb deletion of Corfu delta beta-thalassemia in a non-beta-thalassemia chromosome, Blood, 15, 75:11747
Cited by
Items 501–600 of 721
DNA damage in children with β-thalassemia minor: genotoxicity assessment by comet assay
Menderes, D. K., Emerce, E., Göktaş, T., Cakmak, G. D., & Aslan, D. (2025) · The Turkish Journal of Pediatrics · doi:10.24953/turkjpediatr.2025.4567 · Cited by 2
Meloni, A., Saba, L., Pistoia, L., Zerbini, M., Renne, S., Peritore, G., Fina, P., Positano, V., Longo, F., Spasiano, A., et al. (2025) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.70086 · Cited by 2
Rapid prenatal diagnosis of common beta‐thalassemia mutations in Southeast Asia using pyrosequencing
Ho, S. S. Y., Huan, P. T., Leow, G. H., Ching, L. K., Chiu, L., Law, H. Y., & Koay, E. S. C. (2013) · Prenatal Diagnosis · doi:10.1002/pd.4183 · Cited by 2
Wu, M., Li, J., Yan, J., Zhang, Y., & Li, D. (2016) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12580 · Cited by 2
TGA/Chemometric Test Is Able to Detect the Presence of a Rare Hemoglobin Variant Hb Bibba
Risoluti, R., Caprari, P., Gullifa, G., Diana, L., Luciani, M., Amato, A., & Materazzi, S. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00101 · Cited by 2
Galehdari, H., Bijanzadeh, M., Azarshin, S. Z., Shafee, M., & Heydaran, S. (2021) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-020-01358-w · Cited by 2
Darvishi‐Khezri, H., Naderisorki, M., Zahedi, M., Mortazavi, P., Tajik, F., Nasirzadeh, A., & Karami, H. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1964953 · Cited by 2
Recent advances of CRISPR/Cas9 gene editing in the treatment of β-thalassemia
Xie, Q., Lei, S.-Y., Qu, C., Wu, H., Liu, Y., Huang, P., & Teng, S. (2022) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2022-0109 · Cited by 3
Srisupundit, K., Wanapirak, C., Sirichotiyakul, S., Tongprasert, F., Luewan, S., Traisrisilp, K., & Tongsong, T. (2013) · Prenatal Diagnosis · doi:10.1002/pd.4237 · Cited by 2
Therapeutic Drug Monitoring of Chelating Agent Deferoxamine for β-Thalassemia Major Patients
Ratha, R., & Altaei, T. S. (2013) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2013.48059 · Cited by 2
Yu, N., Kim, H. R., Cha, Y. J., & Park, E. K. (2010) · Annals of Hematology · doi:10.1007/s00277-010-1002-5 · Cited by 2
Wu, M., & Li, D. (2015) · Hemoglobin · doi:10.3109/03630269.2015.1100118 · Cited by 2
Binaghi, G., Congia, D., Dessì, C., Matta, G., Pasqualucci, D., Serra, E., & Porcu, M. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.066 · Cited by 2
Beliefs of Jordanian Children with Thalassemia toward Using Iron Chelation Therapy
Shosha, G. M. A. (2016) · Open Journal of Blood Diseases · doi:10.4236/ojbd.2016.63005 · Cited by 2
The role of anaemia in oxidative and genotoxic damage in transfused β-thalassaemic patients
Ferro, E., Visalli, G., Rosa, M. A. L., Civa, R., Papa, G. R., D’Ascola, D. G., Roccamo, G., Piraino, B., Salpietro, C. D., & Pietro, A. D. (2016) · Hematology · doi:10.1080/10245332.2016.1244034 · Cited by 2
Keikhaei, B., Slehi-fard, P., Nojoumi, S. A., & Khosravi, A. (2017) · Frontiers in Biology · doi:10.1007/s11515-017-1431-9 · Cited by 2
Sayahi, M., Mardasi, F. G., & Kambo, M. S. (2017) · Gene Cell and Tissue · doi:10.5812/gct.64501 · Cited by 2
Complete Blood Cell Count Interpretation for Hypoproliferative Anemias
Patel, D. (2019) · Physician Assistant Clinics · doi:10.1016/j.cpha.2019.02.011 · Cited by 2
Molecular Aspects of Thermal Tolerance and Exertional Heat Illness Susceptibility
Lee, E. C., Bowie, J. S., Fiol, A. P., & Huggins, R. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-27805-2_8 · Cited by 2
Hypoparathyroidism in a Case of Transfusion Dependent Thalassemia
Majumder, A., & Basu, S. (2020) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.035.01.23 · Cited by 2
Zhang, X., Yang, Y., Zhang, H., Du, Z., Liu, H., & Shen, Y. (2021) · American Journal of Hematology · doi:10.1002/ajh.26148 · Cited by 2
Tsai, D., Tai, M., Kao, C.-C., Chen, W.-T., Wu, L.-W., Chiu, C.-C., Tu, M.-Y., Chen, Y., Wu, C., & Su, S. (2021) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000515 · Cited by 2
Akıncı, B., Yenigürbüz, F. D., Tunçez, E., & Öz, Ö. (2021) · Family practice and palliative care · doi:10.22391/fppc.805164 · Cited by 2
Neuroimaging Findings in Pediatric Patients with Thalassemia Major
Akbaş, Y., Köker, S. A., Tuncer, G. Ö., Köker, A., Çoban, Y., Oktay, G., & Yeral, H. (2022) · Hematology Reports · doi:10.3390/hematolrep14010009 · Cited by 2
An Overview on Thalassemia Diagnosis and Management Approach, Literature Review
Manea, T. M., Khan, F. S. A., Alsharyufi, R. M., Alghamdi, K. M., Alzahrani, M. K., Alzubaidi, F. M., Alghanmi, A. A., Almahdawi, T. A., Alhasani, T. M., & Alrajhi, N. N. (2021) · International Journal Of Pharmaceutical Research And Allied Sciences · doi:10.51847/joxooigivq · Cited by 3
Hemoglobinopathies in Perinatal Medicine: Challenges in Management
Dayyabu, A. L. (2022) · Donald School Journal of Ultrasound in Obstetrics & Gynecology · doi:10.5005/jp-journals-10009-1936 · Cited by 2
Suwito, B. E., Adji, A. S., Widjaja, J. S., Angel, S. C. S., Hajiri, A. Z. Z. A., Salamy, N. F. W., & Choirotussanijjah, C. (2023) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2023.11435 · Cited by 4
Ali, M. S., Borhany, M., Butt, A. J., Ali, R. M., Kashif, S. M., Wahaj, M., & Shamsi, T. S. (2023) · Cureus · doi:10.7759/cureus.42069 · Cited by 5
Nambala, P., Mulindwa, J., Noyes, H. A., Alibu, V. P., Nerima, B., Namulondo, J., Nyangiri, O. A., Matovu, E., MacLeod, A., & Musaya, J. (2023) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0011803 · Cited by 1
Salih, M. M., Al-Ziaydi, A. G., & Alzamili, A. H. H. (2023) · Journal of Applied Hematology · doi:10.4103/joah.joah_98_23 · Cited by 2
Fathi, A., Amani, F., & Mazhari, N. (2019) · Materia Socio Medica · doi:10.5455/msm.2019.31.294-297 · Cited by 3
Hashmi, G. P., Qidwai, A., Fernandez, K., & Seul, M. (2020) · BMC Medical Genetics · doi:10.1186/s12881-020-01017-x · Cited by 2
The Global State of Genome EditingPreprint
Siwo, G. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/341198 · Cited by 2
Westin, E. R., Tsao, D., Atay, O., Landry, B. P., Ye, P. P., Chandler-Brown, D. B., Alford, B. D., Hoskovec, J. M., Subramaniam, A., Pawlik, K. M., et al. (2021) · medRxiv · doi:10.1101/2021.09.02.21262837 · Cited by 2
Molecular investigations of β-thalassemic children in Erbil governorate
Hasan, A. N., & Al-Attar, M. S. (2017) · AIP conference proceedings · doi:10.1063/1.5004302 · Cited by 1
Hasani, K. A., Bakathir, A. A., Al-Hashmi, A. K., Rawahi, B. A., & Albakri, A. (2020) · Sultan Qaboos University medical journal · doi:10.18295/squmj.2020.20.03.018 · Cited by 1
Sánchez-Martínez, L. J., Hernández, C. L., Rodríguez, N., Dugoujon, J. M., Novelletto, A., Ropero, P., Pereira, L., & Calderón, R. (2021) · Annals of Human Biology · doi:10.1080/03014460.2021.2000641 · Cited by 1
Genetic bases and modifiers of β-thalassemia in Argentina
Scheps, K. G., Salim, J. P., Varela, V., Basack, N. F., García, E., Crisp, R. L., Chiappe, G., Paula, S. D., Watman, N. P., Zerdiew, A., et al. (2022) · Human Gene · doi:10.1016/j.humgen.2022.201071 · Cited by 1
Qian, H., Li, W., Lin, X., Xu, J., Zhang, X., Zhao, W., Wu, Y., & Liu, W. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.12999 · Cited by 1
Ravichandran, S., Hoffmann, M. H., Petersen, J., Sjø, L. D., Rasmussen, A. Ø., Eidesgaard, A., & Glenthøj, A. B. (2024) · Hemoglobin · doi:10.1080/03630269.2024.2335919 · Cited by 1
Tavassoli, S., Chung, J. H., Panigrahi, A. R., Shahsavar, A., Lal, A., & Singer, S. T. (2024) · Hemoglobin · doi:10.1080/03630269.2024.2410295 · Cited by 1
Majid, I., & Sergeev, Y. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111649 · Cited by 1
van der Meij, E., Smiers, F. J. W., Koopmann, T. T., Krapels, I. P. C., le Poole, K., Lopriore, E., Middeldorp, J. M., Ootjers, C. S., Scharnhorst, V., Scheepers, H. C. J., et al. (2024) · Prenatal Diagnosis · doi:10.1002/pd.6695 · Cited by 1
Zeng, G.-K., Yang, Y., Ge, Y.-Y., Yang, Y., Lai, B.-R., Cao, Y.-B., Yu, X., & Yang, L. (2025) · Hemoglobin · doi:10.1080/03630269.2024.2446371 · Cited by 1
Meloni, A., Pistoia, L., Spasiano, A., Sorrentino, F., Messina, G., Santodirocco, M., Borsellino, Z., Cecinati, V., Positano, V., Restaino, G., et al. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12030103 · Cited by 1
Spectrum of Ophthalmic Manifestations in Patients With Transfusion-Dependent Thalassemia
Jain, P., Ikram, S., Kashiv, Y., Chanchlani, M., Singh, H., & Singhai, A. (2025) · Cureus · doi:10.7759/cureus.82218 · Cited by 1
Volloch, V., & Rits‐Volloch, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094252 · Cited by 3
Khalaf, W. S., Abed, F. H., & Shwayel, A. J. (2025) · Journal of Applied Hematology · doi:10.4103/joah.joah_68_25 · Cited by 1
Hammou, H. A., Elhidar, N., Ouhammou, M., Sansar, W., Fazzani, S., Dhimni, T. E., & Essalam, M. S. (2025) · Hemato · doi:10.3390/hemato6040035 · Cited by 1
Shan, X., Li, Q., Wang, M., Niu, Y., Sun, Z., Ma, X., Wang, T., Tong, X., Zhang, J., & Niu, D. (2025) · Functional & Integrative Genomics · doi:10.1007/s10142-025-01756-1 · Cited by 1
Meloni, A., Saba, L., Cossu, A., Positano, V., Pistoia, L., Longo, F., Cecinati, V., Giovangrossi, P., Clemente, A., & Cau, R. (2025) · Clinical Radiology · doi:10.1016/j.crad.2025.107144 · Cited by 1
Al-Helo, H., Desai, S. A., Varma, T., Garg, P., & Shahiwala, A. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100220 · Cited by 2
Novel isoxazole-containing thiazolidinone: Synthesis, DFT analysis, and pharmacological evaluation
Alotaibi, S. H., & Alotaibi, M. T. (2026) · Arabian Journal of Chemistry · doi:10.25259/ajc_555_2025 · Cited by 1
Assessment of Thalassemia Knowledge among University Students: A Cross-Sectional Study
Shaker, U. A.-B. B., Hassan, N. S., Jaber, F. H., & Alhijaj, B. A. (2026) · Journal of Clinical Practice and Medical Research · doi:10.59324/jcpmr.2026.2(2).12 · Cited by 1
Soliman, A. T., Alyafei, F., Alaaraj, N., Hamed, N., Ahmed, S., & Elawwa, A. (2026) · Thalassemia Reports · doi:10.3390/thalassrep16030018 · Cited by 1
Reactivation of Fetal Hemoglobin in Thalassemia and Sickle Cell Disease
Eridani, S., Avemaria, F., & Mosca, A. (2014) · Thalassemia Reports · doi:10.4081/thal.2014.2196 · Cited by 4
Grody, W. W., & Deignan, J. L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00030-6 · Cited by 1
Audino, A. N., & Yeager, N. D. (2013) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e31827518a3 · Cited by 1
DabbaghBagheri, S., Ghadami, S., Mollazadeh, F., Saadat, A., & Zeinali, S. (2016) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-016-0682-y · Cited by 1
Pocket-sized iron regulators: one size fits all?
Subramaniam, V. N. (2016) · Blood · doi:10.1182/blood-2016-05-716043 · Cited by 1
Anästhesie bei Patienten mit Anämien, Polyzythämien und Methämoglobinämie
Waschke, K. F. (2019) · Springer Reference Medizin · doi:10.1007/978-3-662-54507-2_108 · Cited by 1
Relationship between β-Thalassemia minor and Helicobacter pylori infection.
Zamani, M., Vahedi, A., Tamaddoni, A., Bijani, A., Bagherzade, M., & Shokri‐Shirvani, J. (2018) · PubMed Central · doi:10.22088/cjim.9.1.54 · Cited by 2
Hematologic features of beta-globin gene mutation type (?o) with homozygous beta thalassemia
Özbolat, G., & Tuli, A. (2018) · The Ukrainian Biochemical Journal · doi:10.15407/ubj90.04.115 · Cited by 1
Murad, H., & Moassas, F. (2019) · Hemoglobin · doi:10.1080/03630269.2019.1577254 · Cited by 1
A Curse of Knowledge in Diagnosis of Thalassemia
Al-Jasmi, F. A., Denic, S., & Souid, A. (2020) · European Journal of Medical and Health Sciences · doi:10.24018/ejmed.2020.2.2.196 · Cited by 1
Tiewsiri, K., Manipalviratn, S., Sutheesophon, W., Vanichsetakul, P., Thaijaroen, P., Ketcharoon, P., Bradley, C. K., McArthur, S. J., Krutsawad, W., Marshall, J. T. A., et al. (2020) · BioMed Research International · doi:10.1155/2020/5292090 · Cited by 1
Generalidades y tratamientos emergentes en la Beta-talasemia
Ureña, G. J. A., Hernández, R. K., & Ortiz, J. M. M. (2020) · Revista Medica Sinergia · doi:10.31434/rms.v5i12.549 · Cited by 1
Gupta, M. (2020) · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH · doi:10.36106/ijsr/1631525 · Cited by 1
Assyuhada, M. G. S. N., Saleh, R. M., Rahman, W. S. W. A., Hassan, M. N., Abdullah, W. Z., Azlan, M., & Zulkafli, Z. B. (2021) · Asia-Pacific Journal of Molecular Biology and Biotechnology · doi:10.35118/apjmbb.2021.029.1.02 · Cited by 1
Choubisa, C. A., Jain, M. J., Vardhan, V. D., Budhwani, Y. J., & Hege, A. R. (2022) · Cureus · doi:10.7759/cureus.29999 · Cited by 1
Mahmoud, A. A. S., El-Hamid, M. E.-S. A., El-Hawwary, A. M., Awad, S. M., Abdallah, H. M., Morsi, D. S., & El‐Hawy, M. A. (2022) · Pediatric Hematology/Oncology and Immunopathology · doi:10.24287/1726-1708-2022-21-3-42-46 · Cited by 1
Approved Protein Therapeutics and Their Biochemical Targets
Ramesh, R., & Ravichandran, R. (2023) · Springer eBooks · doi:10.1007/978-981-19-8249-1_7 · Cited by 1
Marchesani, S., Mauro, M. D., Ceglie, G., Grassia, G., Carletti, M., Cristofaro, R. C., Cossutta, M., Curcio, C., & Palumbo, G. A. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1228443 · Cited by 2
Ghasemi, A., Ghaffari, K., Hoseini, F. S., Eghbali, A., Sajadei, N., Falahati, V., & Ghandi, Y. (2023) · International Journal of Hematology-Oncology and Stem Cell Research · doi:10.18502/ijhoscr.v17i4.13912 · Cited by 1
do Amaral, L. C., & Pedrosa, H. A.-S. R. (2023) · Arquivos Brasileiros de Neurocirurgia Brazilian Neurosurgery · doi:10.1055/s-0043-1776267 · Cited by 1
Molecular Analysis and Prenatal Diagnosis of Segregating Β-Thalassemia
Ishfaq, J., Khan, A. H., Khan, B. S., Aziz, T. A., Khalid, F., Noureen, A., & Ali, B. (2023) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs2023175658 · Cited by 2
Yao, Q.-C., Zhai, H.-L., & Wang, H. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i35.8270 · Cited by 1
Nawaz, K., Khan, S. N., Bashir, A., Rehman, A., Khan, M. T. M., Mir, A., & Ahmad, S. (2024) · Cureus · doi:10.7759/cureus.52002 · Cited by 1
Late Presentation of β-Thalassemia Major Patient With Left Hemiparesis: A Case Report
Hussain, A., Singh, A., Arora, S., Gupta, V., & Mallimala, P. R. (2024) · Cureus · doi:10.7759/cureus.52280 · Cited by 1
Mukhopadhyay, S. (2024) · Indian Journal of Obstetrics and Gynecology Research · doi:10.18231/j.ijogr.2024.022 · Cited by 1
Insights in Thalassemia: From Genomics to Clinical Practice
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4486-0 · Cited by 1
Role of blood hepcidin alteration as a biomarker in β-thalassemia patients’ diagnosis
AL-dulaimy, W. Y. M., Sahab, K. S., Mohammed, E. S., & Kadhom, M. A. (2024) · Trends in Immunotherapy · doi:10.24294/ti.v8.i1.4397 · Cited by 1
Jeenduang, N., Horpet, D., Plyduang, T., & Nuinoon, M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e31374 · Cited by 1
Investigating β Thalassemia Patients and Their Growth: A Brief Review and Our Clinical Experience
Mohajeri‐Tehrani, M. R., Arab, F., Salemkar, S., Darvishian, N., Mohseni, F., Larijani, B. A., & Hamidi, Z. (2024) · Journal of Pediatrics Review · doi:10.32598/jpr.12.1.1081.1 · Cited by 1
Jayaram, P. R., Devadas, S., Jain, P., & Gayathri Devi, C. (2024) · Journal of Community Genetics · doi:10.1007/s12687-024-00739-2 · Cited by 1
Simbula, M., Manchinu, M. F., Olla, S., Congiu, M., Vaccargiu, S., Caria, C. A., Poddie, D., & Ristaldi, M. S. (2025) · Biomolecules · doi:10.3390/biom15040565 · Cited by 1
Thalassemia, Endocrine Sequelae
Kyriakou, A., & Skordis, N. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.04488-3 · Cited by 1
Partial Splenectomy in the treatment of an adult with β thalassemia intermedia: A case report
Correia, J. G., Moreira, N., Almeida, C. C., & Reis, L. (2017) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2017.11.011 · Cited by 1
The Effectiveness of Thalassemia Control Measures in the United Arab Emirates
Dhaheri, H. A., & Kim, S. (2018) · International Conference on Control, Artificial Intelligence, Robotics & Optimization (ICCAIRO) · doi:10.1109/iccairo.2018.00020 · Cited by 1
Shoujaa, A., Mukhalalaty, Y., Murad, H., & Al-Quobaili, F. (2019) · Hemoglobin · doi:10.1080/03630269.2019.1670206 · Cited by 1
Economopoulos, D. G., & Triantafyllopoulos, I. Κ. (2019) · PubMed Central · Cited by 1
Laks, K. M., Hirner, C., Gruner, B. A., Coberly, J., Laziuk, K., & Sathi, B. K. (2020) · Case Reports in Hematology · doi:10.1155/2020/8869335 · Cited by 1
Kopparthy, P., Kelkar, A. H., Aggarwal, K., Filippis, S. M. D., & Fletcher, B. (2021) · Cureus · doi:10.7759/cureus.13638 · Cited by 1
Ghosh, M. D., Datta, M. R., Singh, V., & Rana, F. (2021) · Cureus · doi:10.7759/cureus.13872 · Cited by 1
Haddad, L. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-73151-9_4 · Cited by 1
Anthropometric measurements of peri-oral region in a sample of Iraqi thalassemic patients
Al-Taee, R., Al-Saedi, A. I. L., & Nahidh, M. (2022) · Journal of Orthodontic Science · doi:10.4103/jos.jos_148_21 · Cited by 2
Therapeutic Applications of CRISPR/Cas9 Technology for Infectious Diseases
Sharma, G., Rehman, S., & Sharma, A. R. (2022) · Springer eBooks · doi:10.1007/978-981-16-9190-4_25 · Cited by 2
Jalali, H., Karami, H., Mahdavi, M. R., & Mahdavi, M. (2022) · Thalassemia Reports · doi:10.3390/thalassrep12030015 · Cited by 1
Panja, A., Das, B., Dolai, T. K., & Choudhury, S. M. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.109999 · Cited by 5
Splenectomy for people with thalassaemia major and intermedia
Mathew, M. E., Sharma, A., Fahad, S., & Aravindakshan, R. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010517 · Cited by 1
Metadata
- Authors
- Cao, A., & Galanello, R.
- Affiliations
- National Research Council (IT)
- University of Cagliari (IT)
- Corresponding author
- Cao, Antonio
- Venue
- Genetics in Medicine
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 12
- Issue
- 2
- Pages
- 61-76
- ISSN
- 1098-3600 (ISSN-L)
- OpenAlex
- W4210970197
- Cited by
- 722
- References
- 4
- Citations by year
- 2026: 43 · 2025: 48 · 2024: 63 · 2023: 61 · 2022: 60 · 2021: 66 · 2020: 69 · 2019: 64 · 2018: 48 · 2017: 58 · 2016: 52 · 2015: 24 · 2014: 14 · 2013: 20 · 2012: 15
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4370 d)
- Locations
- Genetics in Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- beta-thalassemia, beta-globin gene, HBB mutations, thalassemia major, thalassemia intermedia, transfusion-dependent anemia, iron chelation therapy, bone marrow transplantation, fetal hemoglobin induction, genetic counseling, prenatal diagnosis, chromosome 11
- MeSH terms
- Female, Multigene Family, Genetic Testing, Globins, Genetic Carrier Screening, Humans, Pregnancy, Prenatal Diagnosis, Bone Marrow Transplantation, beta-Thalassemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.